title: Transient delayed facial nerve palsy after inferior alveolar nerve block anesthesia.
abstract: Facial nerve palsy, as a complication of an inferior alveolar nerve block anesthesia, is a rarely reported incident. Based on the time elapsed, from the moment of the injection to the onset of the symptoms, the paralysis could be either immediate or delayed. The purpose of this article is to report a case of delayed facial palsy as a result of inferior alveolar nerve block, which occurred 24 hours after the anesthetic administration and subsided in about 8 weeks. The pathogenesis, treatment, and results of an 8-week follow-up for a 20-year-old patient referred to a private maxillofacial clinic are presented and discussed. The patient's previous medical history was unremarkable. On clinical examination the patient exhibited generalized weakness of the left side of her face with a flat and expressionless appearance, and she was unable to close her left eye. One day before the onset of the symptoms, the patient had visited her dentist for a routine restorative procedure on the lower left first molar and an inferior alveolar block anesthesia was administered. The patient's medical history, clinical appearance, and complete examinations led to the diagnosis of delayed facial nerve palsy. Although neurologic occurrences are rare, dentists should keep in mind that certain dental procedures, such as inferior alveolar block anesthesia, could initiate facial nerve palsy. Attention should be paid during the administration of the anesthetic solution.
authors.affiliation: University of Athens, School of Dental Medicine, Athens, Greece. ftzerbos@dent.uoa.gr
authors.forename: Fotios H
authors.initials: FH
authors.lastname: Tzermpos
authors.forename: Alina
authors.initials: A
authors.lastname: Cocos
authors.forename: Matthaios
authors.initials: M
authors.lastname: Kleftogiannis
authors.forename: Marissa
authors.initials: M
authors.lastname: Zarakas
authors.forename: Ioannis
authors.initials: I
authors.lastname: Iatrou
mesh_terms: D000766:Anesthesia, Dental / Q000009:adverse effects*; D000779:Anesthetics, Local / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002355:Carticaine / Q000008:administration & dosage; D003793:Dental Restoration, Permanent; D005158:Facial Paralysis / Q000209:etiology*; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007267:Injections / Q000009:adverse effects; D008340:Mandibular Nerve / Q000187:drug effects*; D018908:Muscle Weakness / Q000209:etiology; D009407:Nerve Block / Q000009:adverse effects*; D011239:Prednisolone / Q000627:therapeutic use; D020127:Recovery of Function / Q000502:physiology; D055815:Young Adult
chemical_list: D000779:Anesthetics, Local; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011239:Prednisolone; D002355:Carticaine